LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

End-To-End Spectroscopy-Based Workflow Solutions for Oligonucleotide Analysis

Brochures and specifications | 2023 | Agilent TechnologiesInstrumentation
GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Significance of the Topic


In oligonucleotide research and genetic testing, accurate characterization of short nucleic acid polymers is critical to ensure product identity, purity, and compliance with regulatory standards. Integrated analytical workflows streamline the transition from raw materials through production quality control, reducing risk and improving efficiency.

Objectives and Study Overview


This guide presents end-to-end spectroscopy-based solutions for oligonucleotide analysis, covering four key areas: raw material identification, finished product verification, trace elemental impurity detection, and residual solvent quantification. Each workflow is designed to be robust, user-friendly, and compliant with cGMP and regulatory guidelines.

Methodology


  • Raw Material Identification: Employ warehouse-based Raman spectroscopy and laboratory-based FTIR or LC/UV to verify the authenticity and purity of incoming reagents.
  • Finished Product Verification: Use UV-Vis spectrophotometry to determine nucleic acid concentration and melting temperature, providing insight into sequence integrity.
  • Trace Elemental Impurity Analysis: Apply ICP-MS methods aligned with USP<233> and ICH Q3D requirements to detect metal contaminants at trace levels.
  • Residual Solvent Analysis: Implement GC or GC/MS techniques in accordance with USP<467> to separate, identify, and quantify volatile solvents that must be removed from drug products.

Used Instrumentation


  • Raman Spectroscopy: Agilent Vaya handheld system with Vaya software.
  • FTIR Spectroscopy: Agilent Cary 630 FTIR spectrometer with MicroLab Pharma software.
  • Liquid Chromatography: Agilent 1290 Infinity II Bio LC with OpenLab ChemStation.
  • UV-Vis Spectrophotometry: Agilent Cary 3500 Multizone UV-Vis with Cary UV Workstation.
  • ICP-MS: Agilent 7850 ICP-MS (optional 7900 ICP-MS) with I-AS and SPS4 autosamplers and ICP-MS MassHunter software.
  • Gas Chromatography/Mass Spectrometry: Agilent 8890 GC with 8697 headspace sampler or Intuvo 9000 GC, 5977C MSD, managed by OpenLab CDS.

Key Results and Discussion


Each workflow demonstrated high sensitivity, reproducibility, and compliance with regulatory standards. Raman and FTIR analyses enabled rapid screening of raw materials, while LC/UV provided confirmatory separation. UV-Vis assays yielded precise concentration and melting temperature data. ICP-MS workflows achieved sub-ppb detection limits for metal impurities. GC and GC/MS workflows delivered reliable identification and quantification of residual solvents.

Benefits and Practical Applications


These integrated solutions reduce analysis time, enhance data integrity, and support robust QA/QC practices in pharmaceutical development and production laboratories. Automated data processing and secure software environments facilitate regulatory compliance and improve laboratory throughput.

Future Trends and Opportunities


Emerging trends include greater automation, AI-driven spectral interpretation, miniaturized and portable devices, and seamless integration with laboratory information management systems (LIMS) to further accelerate decision-making and data analytics.

Conclusion


Agilent’s end-to-end spectroscopy-based workflows offer comprehensive, reliable methods for oligonucleotide analysis. By addressing critical quality attributes from raw materials to final product verification, these solutions help laboratories meet regulatory requirements and maintain high standards in research and production environments.

References


  • Neo A., Welsby C. Rapid Testing of Solvents Through Amber Bottles Using an Agilent Vaya Handheld Raman Spectrometer. Agilent Technologies Application Note 5994-5929EN, 2023.
  • Pulliere F., Welsby C. Identification of Commercially Available Oligonucleotide Starting Materials Directly Through Containers. Agilent Technologies Application Note 5994-4239EN, 2021.
  • Pulliere F., Welsby C. Differentiating Biopharmaceutical Raw Materials Using Spatially Offset Raman Spectroscopy. Agilent Technologies Application Note 5994-3534EN, 2021.
  • Pulliere F., Welsby C. Rapid Identification of Polysorbates 20 and 80 Directly Through Amber Bottles. Agilent Technologies Application Note 5994-3459EN, 2021.
  • Pulliere F. Rapid Identification of Raw Materials Inside Packaging. Agilent Technologies Application Note 5994-2936EN, 2023.
  • Alwan W., Zieschang F. The Agilent Cary 630 FTIR Spectrometer for Material Identification Applications. Application Note 5994-4992EN, 2022.
  • Best Practice for Nucleic Acid Thermal Stability Measurements Using the Cary 3500 UV-Vis Spectrophotometer. Agilent Technologies White Paper 5994-4028EN, 2022.
  • Alwan W., Rault M. Fast Determination of Thermal Melt Temperature of Double-Stranded Nucleic Acids by UV-Vis Spectroscopy. White Paper 5994-0384EN, 2022.
  • Sanderson J. Residual Solvent Analysis in Hemp Consumer Products Using Headspace Gas Chromatography and Mass Spectrometry. Application Note 5994-5237EN, 2022.
  • Zhang Y., Na S. Analysis of USP<467> Residual Solvents Using the Agilent 8890 GC/FID/5977B MSD System. Application Note 5994-1488EN, 2019.
  • Wieder L., Pan J., Veeneman R. Analysis of USP Method <467> Residual Solvents on the Agilent 8890 GC System. Application Note 5994-0442EN, 2019.
  • Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS. Application Note 5994-6470EN, 2023.
  • Sanderson J., Whitecotton L. Analysis of Artificial Tear Eye Drops for Elemental Impurities. Application Note 5994-1561EN, 2022.
  • Whitecotton L., McCurdy E., Jones C., Liba A. Validating Performance of an Agilent ICP-MS for USP<232>/<233> & ICH Q3D(R2)/Q2(R1). Application Note 5991-8335EN, 2022.
  • USP<232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution. Agilent Technologies White Paper 5991-8149EN, 2021.
  • Jing M., Ni Y., Wang Y., Zhang Z. Determination of Chromium in Gelatin Capsules Using ICP-MS. Application Note 5991-1531EN, 2021.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
End-To-End Workflow Solutions for Therapeutic Peptides
End-To-End Workflow Solutions for Therapeutic Peptides
2025|Agilent Technologies|Brochures and specifications
Therapeutic Peptides Workflow Resource Guide End-To-End Workflow Solutions for Therapeutic Peptides From research discovery to production QA/QC Ensuring Quality in Therapeutic Peptide Development Peptides are short chains of amino acids, which are the "building blocks" of proteins. Some peptide molecules…
Key words
peptide, peptideopenlab, openlabbundle, bundlesoftware, softwareworkflow, workflowadvancebio, advancebiomsd, msdchemstation, chemstationpreparative, preparativeanalysis, analysisagilent, agilentvaya, vayadetect, detectimpurity, impuritypurification
Driving the Field of Oligonucleotide Therapeutics
Image © Agilent Technologies, Inc. 2024 Sponsored by Driving the Field of Oligonucleotide Therapeutics State-of-the-Art Solutions for Oligonucleotide Characterization, Purification, and Manufacturing / Chapter 1: Introduction to Oligonucleotide Therapeutics / Chapter 2: Challenges for Oligonucleotide Synthesis and Production / Chapter…
Key words
labx, labxebook, ebookoligonucleotide, oligonucleotidebio, biooligos, oligosoligonucleotides, oligonucleotidesoligo, oligopurification, purificationanalysis, analysisagilent, agilentsynthesis, synthesisimpurities, impuritiespreparative, preparativepurity, puritysynthetic
Agilent Molecular Spectroscopy Solutions For the pharmaceutical and biopharmaceutical industries
Agilent Molecular Spectroscopy Solutions For the pharmaceutical and biopharmaceutical industries Analytical Workflows for Drug Discovery, Drug Development, and Drug Manufacturing Agilent’s innovative molecular spectroscopy products are designed to meet the application requirements that are critical for pharmaceutical and biopharmaceutical laboratories.…
Key words
vaya, vayacary, caryraman, ramanfluorescent, fluorescentprotein, proteinmeggle, megglesors, sorscuvettes, cuvettesmonohydrate, monohydratefluorescence, fluorescencesack, sackspectroscopy, spectroscopylactose, lactosestudies, studiesyour
Workflow Solutions for Peptide Therapeutics - Application Compendium
Workflow Solutions for Peptide Therapeutics Application Compendium Table of Contents Introduction4 An emerging class of peptide therapeutics: GLP-15 Analytical advances in peptide therapeutics5 Key analyses for synthetic and recombinant peptide therapeutics 6 Types of impurities in peptide therapeutics 7 Agilent…
Key words
peptide, peptidereturn, returncontents, contentsadvancebio, advancebiotable, tableliraglutide, liraglutideagilent, agilentanalysis, analysisinfinitylab, infinitylabimpurities, impuritiessemaglutide, semaglutidesynthetic, syntheticmsd, msdtherapeutics, therapeuticsnotes
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike